Entecavir Recruiting Phase 4 Trials for Liver Cirrhosis Due to Hepatitis B Virus Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02241590Treatment of Liver Cirrhosis Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir